Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Filamin-binding LIM protein 1 (FBLIM1) is a cytoskeletal adaptor protein encoded by the FBLIM1 gene in humans. It features an N-terminal filamin-binding domain, a central proline-rich region, and multiple C-terminal LIM domains. FBLIM1 localizes chiefly at cell junctions, where it connects cell adhesion complexes to the actin cytoskeleton, helping to regulate cell shape, adhesion, and movement. It also localizes in the nucleus and may influence differentiation processes through interactions with transcription factors. FBLIM1 is implicated in the assembly and stabilization of actin filaments, promotes integrin activation, and helps organize signaling complexes that regulate cytoskeletal dynamics and cell-cell contacts. Variants in FBLIM1 are linked to certain diseases such as Kindler syndrome and osteomyelitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Filamin-binding LIM protein 1 (FBLIM1).